Ad
related to: epiglottitis hib vaccine for cats
Search results
Results From The WOW.Com Content Network
Routine vaccination in these nations has led to a dramatic decrease in the incidence of invasive diseases caused by H. influenzae type b such as epiglottitis, meningitis and pneumonia. [28] It has been reported that epiglottitis cases have decreased by 95% since the 1980s following the introduction of the first Hib vaccine. [8]
The Haemophilus influenzae type B vaccine, also known as Hib vaccine, is a vaccine used to prevent Haemophilus influenzae type b (Hib) infection. [ 2 ] [ 3 ] In countries that include it as a routine vaccine , rates of severe Hib infections have decreased more than 90%. [ 2 ]
Feline vaccination is animal vaccination applied to cats. Vaccination plays a vital role in protecting cats from infectious diseases , some of which are potentially fatal. They can be exposed to these diseases from their environment, other pets, or even humans.
This vaccine protects against Hib, but not the other strains of Haemphilus influenzae. It prevents meningitis, Hib pneumonia, Hib epiglottitis (severe throat infection) and other infections that are a result of this disease. This is a series of 4 shots given at 2, 4, 6 months of age and the last is given between 12 and 15 months of age.
ATC code J07 Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
Feline disease refers to infections or illnesses that affect cats. They may cause symptoms, sickness or the death of the animal. Some diseases are symptomatic in one cat but asymptomatic in others. Feline diseases are often opportunistic and tend to be more serious in cats that already have concurrent sicknesses.
Every helpful hint and clue for Tuesday's Strands game from the New York Times.
[3] [4] Vaccines are categorised into conventional and next generation vaccines. [5] [6] Animal vaccines have been found to be the most cost effective and sustainable methods of controlling infectious veterinary diseases. [6] In 2017, the veterinary vaccine industry was valued at US$7 billion and it is predicted to reach US$9 billion in 2024. [7]